Delivery Order SPE2DR25D3001-SPE2DR26F3F6M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,966.62 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract is a firm fixed price delivery order with an ultimate completion date of November 7, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,850.41 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a completion date of December 5, 2025. The pharmaceutical supplies will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,797.06 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL doses), a diabetes medication. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 4, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $1,308.24 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of December 12, 2025. AmerisourceBergen's Conshohocken, Pennsylvania facility serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on October 28, 2025, with completion expected by October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, which serves as the...
- The Defense Logistics Agency awarded a $37,490.02 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL dosage), a diabetes medication. The contract is a firm fixed-price delivery order with no set-aside designation, issued on October 15, 2025, and scheduled for completion by October 16, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,759.08 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL), a diabetes medication. This competitively awarded, firm fixed-price delivery order was finalized on November 18, 2025, with completion expected by November 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to...
- The Defense Logistics Agency awarded a delivery order valued at $1,154.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-competitive delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, was awarded under firm fixed pricing terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3001Indefinite Delivery Contract
- SPE2DR25D3001-SPE2DR26F3F6MDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,025.74 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract has an ultimate completion date of November 26, 2025, and AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military healthcare programs and other federal medical systems worldwide. The company's consistent receipt of competitively awarded contracts demonstrates its established capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/24/25 |